InspireMD, Inc. (NSPR) vs Tevogen Bio Holdings Inc. (TVGN)

A side-by-side comparison of InspireMD, Inc. and Tevogen Bio Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

NSPR

InspireMD, Inc.

$25M

$0.54HealthcareDelayed quote: Oct 6, 2026, 3:50 PM EDT

TVGN

Tevogen Bio Holdings Inc.

$29M

$6.93HealthcareDelayed quote: Oct 6, 2026, 3:49 PM EDT

Total return — NSPR vs TVGN

growth of $100 · dividends reinvested · last 5y

NSPR -87.5% (-34.0%/yr)TVGN -98.7% (-57.9%/yr)NSPR compounded faster over this window

Log scale — wide-divergence pair

NSPR TVGN

NSPR vs TVGN: by the numbers

•TVGN is the larger company ($29M vs $25M market cap).
•Both run net losses; TVGN's is the smaller (0.00% vs -355.17% net margin).

Metrics side by side

Valuation

Metric	NSPR	TVGN
P/S ratio	2.33	N/A
P/B ratio	0.80	N/A

Profitability

Metric	NSPR	TVGN
Gross margin	29.50%	0.00%
Operating margin	-546.97%	0.00%
Net margin	-355.17%	0.00%
ROE	-122.19%	N/A
ROIC	-153.04%	-3850.16%

Growth (annualized)

Metric	NSPR	TVGN
Revenue CAGR (5Y)	27.79%	N/A
Total return CAGR (5Y)	-36.91%	N/A

Go deeper

Full NSPR analysis Full TVGN analysis Interactive comparison tool

Dig into the metrics

InspireMD ROE Tevogen Bio ROE InspireMD operating margin Tevogen Bio operating margin InspireMD revenue growth Tevogen Bio revenue growth InspireMD free cash flow Tevogen Bio free cash flow

InspireMD & Tevogen Bio appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.